Fraxetin inhibits the induction of anti-Fas IgM, tumor necrosis factor-α and interleukin-1β-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63

International Immunopharmacology

Volumn 6, Issue 7, 2006, Pages 1167-1175

  Kuo, Po Lin ^a   Huang, Yu Ting ^a   Chang, Cheng Hsiung ^a   Chang, Jiunn Kae ^a  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Fas; Fraxetin; Interleukin 1 ; Osteoporosis; Tumor necrosis factor

Indexed keywords

ALKALINE PHOSPHATASE; CASPASE 3; CASPASE 8; COUMARIN DERIVATIVE; CYTOKINE; DNA FRAGMENT; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; FRAXETIN; IMMUNOGLOBULIN M; INTERLEUKIN 1; MARKER; OSTEOCALCIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALKALINE PHOSPHATASE; ANTIGENS, CD95; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 3; CASPASE 8; CASPASES; CELL DIFFERENTIATION; CELL LINE; COUMARINS; HUMANS; IMMUNOGLOBULIN M; INTERLEUKIN-1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; OSTEOBLASTS; OSTEOCALCIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646575253     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.02.010     Document Type: Article

References (29)

1. Choy E.H., and Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344 (2001) 907-916
2. Eguchi K. Apoptosis in autoimmune diseases. Intern Med 40 (2001) 275-284
3. Rifas L., and Avioli L.V. A novel T cell cytokine stimulates interleukin-6 in human osteoblastic cells. J Bone Miner Res 14 (1999) 1096-1103
4. Harada S., and Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 423 (2003) 349-355
5. Tanaka Y., Morimoto I., Nakano Y., Okada Y., Hirota S., Nomura S., et al. Osteoblasts are regulated by the cellular adhesion through ICAM-1 and VCAM-1. J Bone Miner Res 10 (1995) 1462-1469
6. Hock J.M., Krishnan V., Onyia J.E., Bidwell J.P., Milas J., and Stanislaus D. Osteoblast apoptosis and bone turnover. J Bone Miner Res 16 (2001) 975-984
7. Okada Y., and Tanaka Y. Immune signals in the context of secondary osteoporosis. Histol Histopathol 19 (2004) 863-866
8. Kawakami A., Eguchi K., Matsuoka N., Tsuboi M., Koji T., Urayama S., et al. Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. J Bone Miner Res 12 (1997) 1637-1646
9. Tsuboi M., Kawakami A., Nakashima T., Matsuoka N., Urayama S., Kawabe Y., et al. Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J Lab Clin Med 134 (1999) 222-231
10. Lemonnier J., Hay E., Delannoy P., Fromigue O., Lomri A., Modrowski D., et al. Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Pathol 158 (2001) 1833-1842
11. Silvestris F., Cafforio P., Calvani N., and Dammacco F. Impaired osteoblastogenesis in myeloma bone disease: role of upregulated apoptosis by cytokines and malignant plasma cells. Br J Haematol 126 (2004) 475-486
12. Molina-Jimenez M.F., Sanchez-Reus M.I., Andres D., Cascales M., and Benedi J. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res 1009 (2004) 9-16
13. Fernandez-Puntero B., Barroso I., Iglesias I., Benedi J., and Villar A. Antioxidant activity of fraxetin: in vivo and ex vivo parameters in normal situation versus induced stress. Biol Pharm Bull 24 (2001) 777-784
14. Martin-Aragon S., Benedi J.M., and Villar A.M. Modifications on antioxidant capacity and lipid peroxidation in mice under fraxetin treatment. J Pharm Pharmacol 49 (1997) 49-52
15. Paya M., Goodwin P.A., De Las Heras B., and Hoult J.R. Superoxide scavenging activity in leukocytes and absence of cellular toxicity of a series of coumarins. Biochem Pharmacol 48 (1994) 445-451
16. Kimura Y., Okuda H., Arichi S., Baba K., and Kozawa M. Inhibition of the formation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins. Biochim Biophys Acta 834 (1985) 224-229
17. Jia T.L., Wang H.Z., Xie L.P., Wang X.Y., and Zhang R.Q. Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochem Pharmacol 65 (2003) 709-715
18. Morais S., Sousa J.P., Fernandes M.H., and Carvalho G.S. In vitro biomineralization by osteoblast-like cells. I. Retardation of tissue mineralization by metal salts. Biomaterials 19 (1998) 13-21
19. Hsu Y.L., Kuo P.L., and Lin C.C. Acacetin inhibits the proliferation of Hep G2 by blocking cell cycle progression and inducing apoptosis. Biochem Pharmacol 67 (2004) 823-829
20. Kuo P.L., Hsu Y.L., Lin T.C., and Lin C.C. Prodelphinidin B-2 3,3′-di-O-gallate from Myrica rubra inhibits proliferation of A549 carcinoma cells via blocking cell cycle progression and inducing apoptosis. Eur J Pharmacol 501 (2004) 41-48
21. Salgame P., Varadhachary A.S., Primiano L.L., Fincke J.E., Muller S., and Monestier M. An ELISA for detection of apoptosis. Nucleic Acids Res 25 (1997) 680-681
22. Wada Y., Kataoka H., Yokose S., Ishizuya T., Miyazono K., Gao Y.H., et al. Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvaria cells. Bone 22 (1998) 479-485
23. Maeda T., Matsunuma A., Kurahashi I., Yanagawa T., Yoshida H., and Horiuchi N. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem 92 (2004) 458-471
24. Romas E., Gillespie M.T., and Martin T.J. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30 (2002) 340-346
25. Nakashima T., Sasaki H., Tsuboi M., Kawakami A., Fujiyama K., Kiriyama T., et al. Inhibitory effect of glucocorticoid for osteoblast apoptosis induced by activated peripheral blood mononuclear cells. Endocrinology 139 (1998) 2032-2040
26. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
27. Nagata S., and Golstein P. The Fas death factor. Science 267 (1995) 1449-1456
28. Tran S.E., Meinander A., Holmstrom T.H., Rivero-Muller A., Heiskanen K.M., Linnau E.K., et al. Heat stress downregulates FLIP and sensitizes cells to Fas receptor-mediated apoptosis. Cell Death Differ 10 (2003) 1137-1147
29. Perlman H., Pagliari L.J., Georganas C., Mano T., Walsh K., and Pope R.M. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med 190 (1999) 1679-1688